Allegion plc (NYSE:ALLE), a significant player in the bio-tech market, has been the subject of various market reports and investment overtures recently. The company's
fair value has been under scrutiny lately. The
British Columbia Investment Management Corp demonstrated their confidence by investing $1.98 million in Allegion. Notably, Allegion's stock performance remained
volatile, underperforming and outperforming the market on different occasions. The company has been singled out as a
Top Momentum and
Growth stock for the long-term. A recent
quarterly dividend was declared to shareholders' delight.
Q2-2024 Financial Results were also reported. Various investment management firms have either
purchased,
sold, or
acquired stakes in Allegion recently. On the corporate front,
Lauren B. Peters was appointed Chair on Allegion's Board of Directors. Upbeat forecasts indicate Allegion is projected to earn
Q3 2025 Earnings of $1.99 per Share. Furthermore, the company recently welcomed
Stacy Cozad as the new General Counsel and acquired
several companies to bolster their business. Nonetheless, experts recommend keeping Allegion on the
watch list due its volatile performance.
Allegion Public Limited Company ALLE News Analytics from Tue, 12 Nov 2013 08:00:00 GMT to Sun, 29 Sep 2024 14:26:49 GMT -
Rating 6
- Innovation -3
- Information 7
- Rumor -2
